-
Prince Harry lawyers call for 'substantial damages' from UK tabloids
-
Tottenham appoint De Zerbi in battle for Premier League survival
-
US Supreme Court rules against ban on 'conversion therapy' for LGBTQ minors
-
Empty streets, markets in central Nigeria's Jos after major shooting
-
Italy delays coal phase-out by over a decade
-
Stocks rise on peace hopes, oil mixed
-
Israel weathers energy shock from Iran war even as world battles crisis
-
US consumers' inflation expectations surge on Mideast war
-
Napoli threaten absent Lukaku with disciplinary action
-
German whale saga continues as struggling animal beached again
-
Chelsea's Cucurella laments 'instability' caused by Maresca exit
-
'Iran will be at World Cup' and play in US, FIFA's Infantino tells AFP
-
Stocks rise on peace hopes, oil flat
-
Senegal enacts law doubling penalty for same-sex relations
-
De Zerbi 'agrees in principle' to become new Tottenham boss - reports
-
Trump says other countries should 'just take' the Strait of Hormuz
-
Russian oil tanker docks in Cuba after US blockade relief
-
Next days in Iran war will be 'decisive': Pentagon chief
-
Indonesia rations fuel as prices soar over Mideast war
-
How Middle East war is driving up shipping costs
-
Russian tanker brings oil to Cuba as US eases blockade
-
Asia to be hit hardest by Iran war energy crisis: Kpler to AFP
-
Huawei reports slowing revenue growth in 2025
-
Sexualised deepfakes targeting actress spur German '#MeToo' moment
-
Australia head to World Cup on a high after crushing Curacao 5-1
-
Italy fertility rate fell to new low of 1.14 in 2025
-
Pakistan cricketer Zaman gets two-match PSL ban for ball tampering
-
Oil prices rise, stocks mixed on Iran war uncertainty
-
In Beirut's largest stadium, displaced people with disabilities face 'ordeal'
-
Deposed and detained: Niger president's fate unclear nearly three years on
-
Newcastle say no manager change 'at the moment'
-
Newly-hatched rare Indian bustard chick gets 50-strong guard
-
Stranded whale frees itself again off German coast
-
Archaeologists forced by Mideast war to cut short Iraq digs
-
Stranded whale frees itself again off German coast and disappears
-
Thailand's king endorses new cabinet
-
China bans entombing cremated remains in empty flats
-
Calls grow for 15-year-old Suryavanshi to make India bow
-
Stocks slip, oil swings after report says Trump willing to end war
-
Pakistan cricketer Naseem fined record $71,500 for minister criticism
-
China teen diving prodigy nearly retired after 'reaching mental limit'
-
Myanmar junta chief elected vice-president
-
Russian tanker set to deliver oil to crisis-hit Cuba
-
Iran fires missiles across Middle East as Trump threatens oil hub
-
Indonesia summons Google, Meta for 'not complying' with teen social media ban: minister
-
Wembanyama at the double as Spurs beat Bulls
-
Australia investigates tech giants over social media ban breaches
-
Hindu devotional clubbing sways India's youth
-
Oil slips, stocks rise as report says Trump willing to end war
-
Mind games: How football stars are fuelling chess boom
French inventor of abortion pill calls Wyoming ban 'scandalous'
French scientist Etienne-Emile Baulieu, known as the father of the abortion pill, said it was "scandalous" and "a setback for women's freedom" that the US state of Wyoming has banned the drug.
Baulieu, who at the age of 96 is still working on treatments for depression and Alzheimer's, did not mince his words about the ban.
"It is a setback for women's freedom, particularly for those in the most precarious position who do not have the means to go to another state" to get an abortion, he told AFP in an interview.
Last week Wyoming became the first US state to outlaw the use of the abortion pill.
It was the latest point marked for conservative anti-abortion activists in the United States after the Supreme Court overturned the constitutional right to the procedure last year, leaving the policy to individual states.
Baulieu said he had dedicated a large part of his life to "increasing the freedom of women," and the ban was a step in the opposite direction.
Born in Strasbourg in 1926 to Jewish parents, Baulieu was raised by his feminist mother after his father, a doctor, died when he was a boy. At the age of 15, Baulieu joined the French resistance against Nazi occupation.
He went on to become a self-described "doctor who does science," specialising in the field of steroid hormones.
Invited to work in the United States, Baulieu was noticed in 1961 by Gregory Pincus, known as the father of the contraceptive pill, who convinced him to focus on sex hormones.
Back in France, Baulieu designed a way to block the effect of the hormone progesterone, which is essential for the egg to implant in the uterus after fertilisation.
"I wanted to make a contragestive," which stops gestation, he told AFP.
Partnering with the French Roussel-Uclaf laboratory, the oral drug RU-486, also known as mifepristone, was developed in 1982, providing a safe and inexpensive alternative to surgical abortion.
But there was a long battle for the drug to become authorised in the United States, where anti-abortion activists dubbed it the "death pill".
- 'Fanaticism and ignorance' -
In early March, French President Emmanuel Macron praised Baulieu's resilience when he presented the scientist with the Grand-Croix de la Legion d'Honneur, the top rank in France's honours system.
"You, a Jew and a resistance fighter, you were overwhelmed with the most atrocious insults and even compared to Nazi scientists," Macron said.
"But you held on, for the love of freedom and science."
Baulieu's wife Simone Harari Baulieu, a media producer in France, said "adversity slides off him like water off a duck's back".
She added that the recent "step backwards" in the United States was propelled by "fanaticism and ignorance".
Even at age 96, Baulieu heads into his office at the Kremlin-Bicetre University Hospital in the southern suburbs of Paris three times a week.
Stacks of photos, diplomas and binders contain "the work of a lifetime," the scientist said, adding that he still wants to "be useful".
His latest award is pinned to his blue suit, but Baulieu said he "never seriously hoped to receive such honours".
"It was a pleasure, but what interests me is improving people's health."
- 'Driving force' -
The team in his lab are continuing research he began years ago aiming to prevent the development of Alzheimer's disease, as well as treatment for severe depression, for which clinical trials begin in the coming months.
Baulieu said "there is no reason we cannot find treatments" for both illnesses, which have stubbornly evaded many previous attempts.
Julien Giustiniani, the team leader at the Baulieu Institute, which was created to finance research into dementia, said Baulieu was "always enthusiastic".
"He is a driving force for us," Giustiniani said.
Though Baulieu now uses a cane to walk, he exudes a tireless energy.
He partly credits using DHEA, a natural hormone produced by the adrenal gland, which Baulieu first described in the 1960s and has been touted as an anti-ageing supplement.
The causes that have dominated his life were "women, brain health and longevity," Baulieu said.
"I would be bored if I did not work anymore," he added.
G.P.Martin--AT